Sahebi, F <br/><br/>
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma.  [electronic resource] 

 -  Bone marrow transplantation  May 2006 
 - 825-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1705339  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--therapeutic use<br/>Combined Modality Therapy<br/>Disease Progression<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--blood supply<br/>Neoplasm Staging<br/>Stem Cell Transplantation--adverse effects<br/>Survival Analysis<br/>Survivors<br/>Thalidomide--therapeutic use<br/>Time Factors<br/>Transplantation, Autologous<br/>Treatment Outcome